Cross-presentation by dendritic cells

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Nature reviews. Immunology

• Publication date

  2012-07-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nri3254PMID 22790179
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A CD74-DEPENDENT MHC CLASS I ENDOLYSOSOMAL CROSS-PRESENTATION PATHWAY

  2012cited by this paper
• Characterization of resident and migratory dendritic cells in human lymph nodes

  2012cited by this paper
• The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells.

  2012cited by this paper
• Cutting Edge: Expression of XCR1 Defines Mouse Lymphoid-Tissue Resident and Migratory Dendritic Cells of the CD8α+ Type

  2011cited by this paper
• CD8α(+) dendritic cells are the critical source of interleukin-12 that controls acute infection by Toxoplasma gondii tachyzoites.

  2011cited by this paper
• Dendritic Cells and Hepatocytes Use Distinct Pathways to Process Protective Antigen from Plasmodium in vivo

  2011cited by this paper
• Lymph node stroma broaden the peripheral tolerance paradigm.

  2011cited by this paper
• Sec22b regulates phagosomal maturation and antigen crosspresentation by dendritic cells.

  2011cited by this paper
• Mannose receptor polyubiquitination regulates endosomal recruitment of p97 and cytosolic antigen translocation for cross-presentation

  2011cited by this paper
• CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens.

  2011cited by this paper
• Type I interferon is selectively required by dendritic cells for immune rejection of tumors

  2011cited by this paper
• Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells

  2011cited by this paper
• Cross-dressed dendritic cells drive memory CD8+ T-cell activation after viral infection

  2011cited by this paper
• The Acquisition of Antigen Cross-Presentation Function by Newly Formed Dendritic Cells

  2011cited by this paper
• A proteasome‐dependent, TAP‐independent pathway for cross‐presentation of phagocytosed antigen

  2011cited by this paper
• Targeting DC-SIGN via its neck region leads to prolonged antigen residence in early endosomes, delayed lysosomal degradation, and cross-presentation.

  2011cited by this paper
• Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A

  2011cited by this paper
• Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses.

  2011cited by this paper
• Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity.

  2011cited by this paper
• Road to Ruin: Targeting Proteins for Degradation in the Endoplasmic Reticulum

  2011cited by this paper
• Visualizing the innate and adaptive immune responses underlying allograft rejection by two-photon microscopy

  2011cited by this paper
• Phagosomal proteolysis in dendritic cells is modulated by NADPH oxidase in a pH‐independent manner

  2011cited by this paper
• Faculty Opinions recommendation of CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens.

  2011cited by this paper
• Type I IFNs Control Antigen Retention and Survival of CD8α+ Dendritic Cells after Uptake of Tumor Apoptotic Cells Leading to Cross-Priming

  2011cited by this paper
• Human Dendritic Cell Subsets from Spleen and Blood Are Similar in Phenotype and Function but Modified by Donor Health Status

  2011cited by this paper
• Heat shock protein 90 (HSP90) contributes to cytosolic translocation of extracellular antigen for cross-presentation by dendritic cells

  2011cited by this paper
• The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8α+ dendritic cells

  2010cited by this paper
• Lymph node fibroblastic reticular cells directly present peripheral tissue antigen under steady-state and inflammatory conditions

  2010cited by this paper
• Sipuleucel-T immunotherapy for castration-resistant prostate cancer.

  2010cited by this paper
• Temporal changes in dendritic cell subsets, cross-priming and costimulation via CD70 control CD8+ T cell responses to influenza

  2010cited by this paper
• Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens

  2010cited by this paper
• Functional Divergence among CD103+ Dendritic Cell Subpopulations following Pulmonary Poxvirus Infection

  2010cited by this paper
• Fusion Proteins for Versatile Antigen Targeting to Cell Surface Receptors Reveal Differential Capacity to Prime Immune Responses

  2010cited by this paper
• Quantitative proteomics reveals subset-specific viral recognition in dendritic cells.

  2010cited by this paper
• CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells

  2010cited by this paper
• Lymph node fibroblastic reticular cells directly present peripheral tissue antigen under steady-state and inflammatory conditions

  2010cited by this paper
• Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8α+ dendritic cells

  2010cited by this paper
• Lymph node–resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation

  2010cited by this paper
• Direct Presentation Is Sufficient for an Efficient Anti-Viral CD8+ T Cell Response

  2010cited by this paper
• Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells

  2010cited by this paper
• Empowering malaria vaccination by drug administration.

  2010cited by this paper
• The CD8+ dendritic cell subset

  2010cited by this paper
• Differential expression of pathogen-recognition molecules between dendritic cell subsets revealed by plasma membrane proteomic analysis.

  2010cited by this paper
• Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8α+ conventional dendritic cells

  2010cited by this paper
• Defective Cross-Presentation of Viral Antigens in GILT-Free Mice

  2010cited by this paper
• NADPH oxidase activity controls phagosomal proteolysis in macrophages through modulation of the lumenal redox environment of phagosomes

  2010cited by this paper
• Route of Antigen Uptake Differentially Impacts Presentation by Dendritic Cells and Activated Monocytes

  2010cited by this paper
• Efficient and versatile manipulation of the peripheral CD4+ T-cell compartment by antigen targeting to DNGR-1/CLEC9A

  2010cited by this paper
• Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming. 1976.

  2010cited by this paper
• Protection against a malaria challenge by sporozoite inoculation.

  2009cited by this paper
• Identification of a dendritic cell receptor that couples sensing of necrosis to immunity

  2009cited by this paper
• IRAP Identifies an Endosomal Compartment Required for MHC Class I Cross-Presentation

  2009cited by this paper
• The thymic medulla: a unique microenvironment for intercellular self-antigen transfer

  2009cited by this paper
• The GTPase Rab3b/3c-positive recycling vesicles are involved in cross-presentation in dendritic cells

  2009cited by this paper
• Differential rates of replacement of human dermal dendritic cells and macrophages during hematopoietic stem cell transplantation

  2009cited by this paper
• Dynamic Imaging of CD8+ T Cells and Dendritic Cells during Infection with Toxoplasma gondii

  2009cited by this paper
• Induction of peripheral CD4+ T‐cell tolerance and CD8+ T‐cell cross‐tolerance by dendritic cells

  2009cited by this paper
• Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells

  2009cited by this paper
• Respiratory Syncytial Virus-Induced Activation and Migration of Respiratory Dendritic Cells and Subsequent Antigen Presentation in the Lung-Draining Lymph Node

  2009cited by this paper
• Antigen storage compartments in mature dendritic cells facilitate prolonged cytotoxic T lymphocyte cross-priming capacity

  2009cited by this paper
• Long‐lasting cross‐presentation of tumor antigen in human DC

  2009cited by this paper
• Langerhans Cells Are Not Required for the CD8 T Cell Response to Epidermal Self-Antigens 1

  2009cited by this paper
• The small GTPase Rac2 controls phagosomal alkalinization and antigen crosspresentation selectively in CD8(+) dendritic cells.

  2009cited by this paper
• Different cross-presentation pathways in steady-state and inflammatory dendritic cells

  2009cited by this paper
• Selective expression of the chemokine receptor XCR1 on cross-presenting dendritic cells determines cooperation with CD8+ T cells.

  2009cited by this paper
• Membrane vesicles as conveyors of immune responses

  2009cited by this paper
• Targeting proteins to distinct subcellular compartments reveals unique requirements for MHC class I and II presentation

  2009cited by this paper
• Characterization of an Immediate Splenic Precursor of CD8+ Dendritic Cells Capable of Inducing Antiviral T Cell Responses1

  2009cited by this paper
• Differential roles of migratory and resident DCs in T cell priming after mucosal or skin HSV-1 infection

  2009cited by this paper
• The origin and development of nonlymphoid tissue CD103+ DCs

  2009cited by this paper
• TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection

  2009cited by this paper
• Differential Migration of Epidermal and Dermal Dendritic Cells during Skin Infection1

  2009cited by this paper
• Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation.

  2008cited by this paper
• Lentiviral-Mediated Transcriptional Targeting of Dendritic Cells for Induction of T Cell Tolerance In Vivo1

  2008cited by this paper
• The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement.

  2008cited by this paper
• Langerin Expressing Cells Promote Skin Immune Responses under Defined Conditions1

  2008cited by this paper
• Constitutive crosspresentation of tissue antigens by dendritic cells controls CD8+ T cell tolerance in vivo.

  2008cited by this paper
• The Kidney-Renal Lymph Node-System Contributes to Cross-Tolerance against Innocuous Circulating Antigen1

  2008cited by this paper
• Selective suicide of cross-presenting CD8+ dendritic cells by cytochrome c injection shows functional heterogeneity within this subset

  2008cited by this paper
• Cutting Edge: Langerin/CD207 Receptor on Dendritic Cells Mediates Efficient Antigen Presentation on MHC I and II Products In Vivo1

  2008cited by this paper
• Clearance of influenza virus from the lung depends on migratory langerin+CD11b− but not plasmacytoid dendritic cells

  2008cited by this paper
• Deletional Tolerance Mediated by Extrathymic Aire-Expressing Cells

  2008cited by this paper
• Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans

  2008cited by this paper
• Batf3 Deficiency Reveals a Critical Role for CD8α+ Dendritic Cells in Cytotoxic T Cell Immunity

  2008cited by this paper
• Antigen-presentation properties of plasmacytoid dendritic cells.

  2008cited by this paper
• Direct priming of antiviral CD8+ T cells in the peripheral interfollicular region of lymph nodes

  2008cited by this paper
• CD11c provides an effective immunotarget for the generation of both CD4 and CD8 T cell responses

  2008cited by this paper
• NADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells.

  2008cited by this paper
• Primary CD8+ T-Cell Response to Soluble Ovalbumin Is Improved by Chloroquine Treatment In Vivo

  2008cited by this paper
• Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I

  2008cited by this paper
• CLEC9A Is a Novel Activation C-type Lectin-like Receptor Expressed on BDCA3+ Dendritic Cells and a Subset of Monocytes

  2008cited by this paper
• Blood-stage Plasmodium infection induces CD8+ T lymphocytes to parasite-expressed antigens, largely regulated by CD8α+ dendritic cells

  2008cited by this paper
• Dendritic Cell-Induced Memory T Cell Activation in Nonlymphoid Tissues

  2008cited by this paper
• Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells.

  2008cited by this paper
• Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin.

  2008cited by this paper
• Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation

  2008cited by this paper
• Cancer immunotherapy by dendritic cells.

  2008cited by this paper
• Antigen crosspresentation by human plasmacytoid dendritic cells.

  2007cited by this paper
• Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state

  2007cited by this paper
• Deletional Self-Tolerance to a Melanocyte/Melanoma Antigen Derived from Tyrosinase Is Mediated by a Radio-Resistant Cell in Peripheral and Mesenteric Lymph Nodes1

  2007cited by this paper

• The distinct roles of ROS in tumor immunity: from mechanisms to immunotherapeutic applications

  2026cites this paper
• Hyperbranched polycation-based hierarchical assembles as vaccine carrier for cascaded antigen delivery and enhanced immunity response.

  2026cites this paper
• Regnase-1 in cDC1 controls T cell priming and shapes the dynamics of experimental autoimmune encephalomyelitis

  2026cites this paper
• The Progress of Active Immunotherapy for Parkinson’s Disease

  2026cites this paper
• Cohesin-mediated chromatin organization controls the differentiation and function of dendritic cells.

  2026cites this paper
• Cross-presentation of dead cell-associated antigens shapes the neoantigenic landscape of tumor immunity

  2026cites this paper
• Immune dysregulation in Mycoplasma pneumoniae pneumonia: mechanistic controversies and clinical translation from inflammatory dysregulation and immune evasion to chronic injury

  2026cites this paper
• Intratumoural vaccination via checkpoint degradation-coupled antigen presentation

  2026cites this paper
• From Damage Signals to Immune Modulators: Oxidized Lipids in Immunometabolic Inflammation.

  2026cites this paper
• Neuroimmune circuits in respiratory pathophysiology: decoding molecular crosstalk for precision therapeutic targeting

  2026cites this paper
• Tumor-activated dual metabolic nanomodulator turns over tolerogenic tumor control and unleashes systemic immune responses

  2026cites this paper
• Spacer-engineered carboxylated curdlan derivatives for dendritic cell activation and cancer immunotherapy

  2026cites this paper
• Harnessing Vaccines in the Treatment of Solid Tumors: Advances, Challenges, and Future Directions.

  2026cites this paper
• How crosstalk at the immune synapse shapes T cell and dendritic cell biologys.

  2026cites this paper
• mRNA and Peptide Vaccines in Melanoma-Current Landscape and Future Direction.

  2026cites this paper
• CD8+ T cells are primed by cDC1 and exacerbate tau-mediated neurodegeneration

  2026cites this paper
• Peptide-Based Cancer Vaccines: Engineering Immune Precision Against Tumor Evolution

  2025cites this paper
• Oncolytic virus and immunogenic cell death in cancer therapy

  2025cites this paper
• Copy number variation and evolution of MHC class I and II genes in lovebirds (Agapornis, Psittaculidae, Psittaciformes)

  2025cites this paper
• Modulating antigen processing through metal–organic frameworks to bias adaptive immunity

  2025cites this paper
• Heterologous prime-boost vaccination with VLA2001 and an ORFV-based vector enhances spike- and nucleocapsid-specific immunity in mice

  2025cites this paper
• Biomimetic nanovaccines with self-adjuvant effects induced broad-spectrum neutralizing antibodies against SARS-CoV-2 infection in rodents

  2025cites this paper
• Engineered MS2 Virus Capsids for Cellular Display of Peptide Antigens

  2025cites this paper
• MARCO+ Tumor‐Associated Macrophages Impede CD8+ T Cell Immunity to Facilitate Immunotherapy Resistance in Renal Cell Carcinoma

  2025cites this paper
• Immune-activating cationic lipo-polypeptides for oncolytic immunotherapy in triple negative breast cancer

  2025cites this paper
• Controlling intracellular processing to enhance spherical nucleic acid immune stimulation

  2025cites this paper
• Enhancing anti-tumour immunity through modulating dendritic cell activation by combination therapy with a novel TLR2 agonist and PD-L1 Blockade

  2025cites this paper
• Personalized Cancer Vaccines: Current Advances and Emerging Horizons

  2025cites this paper
• Innate Lymphoid Cells and Trained Innate Immunity in Cardiovascular Disease: Mechanistic Insights, Immunopathology, and Emerging Translational Opportunities.

  2025cites this paper
• Outer membrane vesicles as next-generation vaccine platforms: Mechanisms of antigen presentation.

  2025cites this paper
• Ms4a7 expression in cDC1s determines cross-presentation and antitumor immunity.

  2025cites this paper
• The IRE1/XBP1s Axis Regulates Innate Immune Responses in Conventional Dendritic Cells During ZIKV Infection

  2025cites this paper
• News from the T cell trogocytosis front.

  2025cites this paper
• Dendritic cells-derived extracellular vesicles in tumourigenesis: From biological roles to clinical implications.

  2025cites this paper
• Atorvastatin-Loaded Mineralized Vaccine Reprograms Endosomal Trafficking to Amplify STING-Driven Cancer Immunotherapy.

  2025cites this paper
• Resiquimod-induced nanovaccine (RINV) for personalized cancer immunotherapy.

  2025cites this paper
• An In Vitro Approach to Prime or Boost Human Antigen-Specific CD8+ T Cell Responses: Applications to Vaccine Studies

  2025cites this paper
• A Milestone in the Shift from “Passive Killing” to “Active Immunomodulation” in Cancer Treatment—Progress in Melanoma Vaccine Research

  2025cites this paper
• Dendritic cells: understanding ontogeny, subsets, functions, and their clinical applications

  2025cites this paper
• Cascade-heterogated proton nanotransistors for multiplex pH-interval imaging

  2025influential citation
• Interactions Between the Innate and Adaptive Immune Responses.

  2025cites this paper
• Status and Prospects of Glioblastoma Multiforme Treatments

  2025cites this paper
• Matrix-M adjuvant triggers inflammasome activation and enables antigen cross-presentation through induction of lysosomal membrane permeabilization

  2025cites this paper
• Design and Characterization of an Anti-Clec9a Antibody Armed with CpG Oligonucleotides To Enable Targeted Delivery of Adjuvant to Cross-Presenting Dendritic Cells.

  2025cites this paper
• Enhancing DC cancer vaccine by allogeneic MHC class II expression and Treg depletion

  2025cites this paper
• The impact of Panx1 on inflammation, immunity, and cancer: a comprehensive review

  2025cites this paper
• Antigens and adjuvants co-stabilized Pickering emulsions amplify immune responses of subunit vaccines.

  2025cites this paper
• Development of Dendritic Cell Membrane-Coated Nanoparticles for Antigen-Specific T‑Cell Engagement

  2025cites this paper
• Unique Features and Collateral Immune Effects of mRNA-LNP COVID-19 Vaccines: Plausible Mechanisms of Adverse Events and Complications

  2025cites this paper
• Widely conserved miRNAs in buffalo milk extracellular vesicles survive gastrointestinal digestion and potentially target neural and immunomodulatory contexts

  2025cites this paper
• Optimized Ex Vivo Differentiation of CD103+ Dendritic Cells and High-Efficiency Retroviral Transduction of Mouse Bone Marrow HSCs

  2025cites this paper
• Uncovering functional INDELs responsible for splice sites in sheep with different immune profiles naturally exposed to gastrointestinal nematode infection

  2025influential citation
• Innovative gene engineering and drug delivery systems for dendritic cells in cancer immunotherapy

  2025cites this paper
• Peptide vaccine formulations with structurally distinct STING agonist drugamers induce discrete, efficacious antitumor responses

  2025cites this paper
• PI3Kδ Bridges Microbial Surveillance with Antigen Presentation to Reinforce Intestinal Immunity

  2025cites this paper
• Exploring the Pivotal Functions of Tertiary Lymphoid Structures in Cancer Prognosis and Immunotherapy Outcomes

  2025cites this paper
• PROTAC-based nanoantigens promote cross-presentation and trafficking of dendritic cell vaccine for enhanced antitumor efficacy

  2025cites this paper
• CD74 regulates antitumor immunity in melanoma by reprogramming dendritic cell immunogenicity and migration

  2025cites this paper
• Alkaline phosphatase-responsive lipid-like polyphosphonitrile nanovesicles to enhance immunotherapy and inhibit metastasis of triple-negative breast cancer

  2025cites this paper
• Integrated transcriptome study reveals a stress response state CD4 +T cells related to immune tolerance in breast cancer

  2025cites this paper
• The immune system in cardiovascular diseases: from basic mechanisms to therapeutic implications

  2025cites this paper
• Dendritic cells instruct T cell anti-tumor immunity and immunotherapy response

  2025cites this paper
• Cholesterol‐Derived Mannosylated Polypeptide‐Formed Lipid Nanoparticles for Efficient in Vivo mRNA Delivery

  2025cites this paper
• Hairy Cell Leukemia and Its Mimics: A Case-Based Exploration of Diagnostic Complexity

  2025cites this paper
• Adoptively transferred macrophages for cancer immunotherapy

  2025cites this paper
• Innate Immunity in Helicobacter pylori Infection and Gastric Oncogenesis

  2025cites this paper
• A polyvalent vaccine for selectively killing tumor-associated bacteria to prevent cancer metastasis

  2025cites this paper
• Galloylated Toll-Like Receptor 7/8 Agonist Nanovaccine for Enhanced Tumor Antigen Delivery in Personalized Immunotherapy.

  2025cites this paper
• Reprogramming the Tolerogenic Immune Response Against Pancreatic Cancer Metastases by Lipid Nanoparticles Delivering a STING Agonist Plus Mutant KRAS mRNA

  2025cites this paper
• Inherent immunity and adaptive immunity: Mechanism and role in AECOPD

  2025cites this paper
• White adipose tissue in type 2 diabetes and the effect of antidiabetic drugs

  2025cites this paper
• Osteopontin in Chronic Inflammatory Diseases: Mechanisms, Biomarker Potential, and Therapeutic Strategies

  2025cites this paper
• Glioblastoma Cell Lysate and Adjuvant Nanovaccines via Strategic Vaccination Completely Regress Established Murine Tumors

  2025cites this paper
• Regulated cell death and DAMPs as biomarkers and therapeutic targets in normothermic perfusion of transplant organs. Part 2: implementation strategies

  2025cites this paper
• Lipid Coating of Mesoporous Silica Nanoparticles Leads to Efficient Antigen Delivery to Lymph Nodes for Cancer Vaccination.

  2025cites this paper
• Matrix-M® adjuvant triggers inflammasome activation and enables antigen cross-presentation through induction of lysosomal membrane permeabilization

  2025cites this paper
• A review of the progress and challenges of developing dendritic-based vaccines against hepatitis B virus (HBV).

  2025cites this paper
• Migrasomes: key players in immune regulation and promising medical applications

  2025cites this paper
• KDM5A enhances MHC-I antigen presentation and potentiates antitumor immunity unleashed by immune checkpoint blockade

  2025cites this paper
• Nanomaterial Adjuvants for Veterinary Vaccines: Mechanisms and Applications

  2025cites this paper
• Immunostimulatory Pickering emulsion for oral vaccine delivery

  2025cites this paper
• Maximizing Efficacy of Cancer Nanovaccines and Immune Cells Landscape in Responders and Non‐Responders to Immunotherapy

  2025cites this paper
• Immunogenicity of neoantigens: From CAR-T cell to various vaccines.

  2025cites this paper
• The Biology of Dendritic Cells: In Health and Disease.

  2025cites this paper
• Balancing Immunity: GSK-3’s Divergent Roles in Dendritic Cell-Mediated T-Cell Priming and Memory Responses

  2025cites this paper
• Targeting HK3 in tumor-associated macrophages enhances antitumor immunity through augmenting antigen cross-presentation in cervical cancer

  2025cites this paper
• Immune Responses of Dendritic Cells to Zoonotic DNA and RNA Viruses

  2025cites this paper
• Antioxidant Cerium Oxide Nanoparticle Coatings Impart Immunomodulatory Effects by Suppressing Antigen-Specific Cytotoxic T Cell Activation.

  2025cites this paper
• Defects in antigen processing and presentation: mechanisms, immune evasion and implications for cancer vaccine development

  2025cites this paper
• 1,2-naphthoquinone enhances IFN-γ-induced MHC-I expression in dendritic cells, thereby inducing CD8 T cell activation.

  2025cites this paper
• The linkage between innate and adaptive immunity: Recent advances in antigen recognition, processing, and presentation in fish

  2025cites this paper
• Engineered T cells stimulate dendritic cell recruitment and antigen spreading for potent anti-tumor immunity

  2025cites this paper
• Harnessing an integrated glyco-nanovaccine technology for enhanced cancer immunotherapy

  2025cites this paper
• Dendritic Cell-Derived Extracellular Vesicles as Therapeutic Cancer Vaccines: Mechanisms and Optimization Strategies.

  2025cites this paper
• Application of in-silico approaches in subunit vaccines: Overcoming the challenges of antigen and adjuvant development.

  2025cites this paper
• CD63-Mediated SARS-CoV-2 RBD Fusion Neoantigen DNA Vaccine Enhances Antitumor Immune Response in a Mouse Panc02 Model via EV-Targeted Delivery

  2025cites this paper
• Development of a novel assay for antigen presentation measurement

  2025cites this paper
• Lnk/Sh2b3 regulates initiation and severity of autoimmune insulitis and contributes to diabetes risk

  2025cites this paper
• Postoperative dendritic cell vaccination in brain metastasis: A real-world retrospective cohort study evaluating survival and safety

  2025cites this paper
• The swarmable magnetic-driven nanorobots for facilitating trans-intestinal mucosal delivery of oral vaccines to enhance mucosal and systemic immune responses

  2025cites this paper